Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rupazolam (zopiclone) plus acupoint magnetic stimulation for insomnia
ChiCTR2600117150Phase 2Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of zopiclone in Insomnia (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Pittsburgh Sleep Quality Index. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
zopiclone
03
Conditions
Insomnia
Beyond the preview
Go deeper on ChiCTR2600117150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117150.